🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this prospective, non-randomized, single-arm, phase 2 study is ...
Status
Completed
Location
Sheba MC
Start Date
2010-03
Trial ID
NCT01085565
Treatments Being Tested
The hypothesis of this feasibility study is that focal treatment with ExAbl...
Status
Completed
Location
University Health Network
Start Date
2010-10
Trial ID
NCT01226576
Treatments Being Tested
The hypothesis of this study is that focal treatment with ExAblate MRgFUS h...
Status
Completed
Location
City of Hope
Start Date
2013-10
Trial ID
NCT01657942
Treatments Being Tested
A study to evaluate the safety and initial effectiveness of the ExAblate 21...
Status
Terminated
Location
City of Hope
Start Date
2009-09
Trial ID
NCT00981578
Treatments Being Tested
A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatm...
Status
Completed
Location
University of California San Diego
Start Date
2008-03
Trial ID
NCT00656305
Treatments Being Tested
The goal of this study is to collect comparative data on safety and efficac...
Status
Completed
Location
Taipei Medical University Hospital
Start Date
2010-05
Trial ID
NCT01091883
Treatments Being Tested
Since prostate specific antigen (PSA) was introduced as a clinical screenin...
Status
Completed
Location
Department of Radiological Sciences, Sapienza University of Rome
Start Date
2011-01
Trial ID
NCT01522118
Treatments Being Tested
This study is intended to show that ExAblate™ MRgFUS is a safe procedure th...
Status
Terminated
Location
Toronto General Hospital
Start Date
2016-06
Trial ID
NCT02968784
Treatments Being Tested
This extended clinical investigation is a multicenter, prospective, single ...
Status
Active Not Recruiting
Location
Stanford University School of Medicine
Start Date
2019-12-19
Trial ID
NCT03998657
Treatments Being Tested